News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
136,392 Results
Type
Article (4358)
Company Profile (95)
Press Release (131934)
Multimedia
Podcasts (4)
Webinars (7)
Section
Business (42086)
Career Advice (209)
Deals (6162)
Drug Delivery (15)
Drug Development (17424)
Employer Resources (18)
FDA (1494)
Job Trends (2789)
News (66227)
Policy (3658)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (294)
Accelerated approval (8)
Adcomms (1)
Allergies (32)
Alliances (11498)
ALS (53)
Alzheimer's disease (431)
Antibody-drug conjugate (ADC) (100)
Approvals (1577)
Artificial intelligence (104)
Autoimmune disease (59)
Automation (12)
Bankruptcy (38)
Best Places to Work (2248)
BIOSECURE Act (14)
Biosimilars (25)
Biotechnology (86)
Bladder cancer (44)
Brain cancer (13)
Breast cancer (189)
Cancer (1345)
Cardiovascular disease (50)
Career advice (201)
Career pathing (5)
CAR-T (122)
Cell therapy (313)
Cervical cancer (9)
Clinical research (15405)
Collaboration (561)
Compensation (277)
Complete response letters (5)
COVID-19 (442)
CRISPR (25)
C-suite (361)
Cystic fibrosis (45)
Data (1937)
Depression (20)
Diabetes (104)
Diagnostics (751)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (92)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (50)
Earnings (13362)
Editorial (5)
Employer resources (18)
Events (26331)
Executive appointments (380)
FDA (2183)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (14)
Funding (476)
Gene editing (54)
Generative AI (12)
Gene therapy (169)
GLP-1 (164)
Government (362)
Guidances (71)
Healthcare (1533)
HIV (8)
Huntington's disease (12)
IgA nephropathy (40)
Immunology and inflammation (68)
Immuno-oncology (13)
Indications (23)
Infectious disease (497)
Inflammatory bowel disease (76)
Inflation Reduction Act (1)
Influenza (34)
Intellectual property (79)
Interviews (18)
IPO (2967)
IRA (4)
Job creations (668)
Job search strategy (184)
JPM (3)
Kidney cancer (3)
Labor market (16)
Layoffs (42)
Leadership (2)
Legal (641)
Liver cancer (16)
Longevity (2)
Lung cancer (124)
Lymphoma (145)
Machine learning (15)
Management (4)
Manufacturing (243)
MASH (19)
Medical device (405)
Medtech (407)
Mergers & acquisitions (3533)
Metabolic disorders (225)
Multiple sclerosis (51)
NASH (1)
Neurodegenerative disease (81)
Neuropsychiatric disorders (15)
Neuroscience (756)
Neurotech (1)
NextGen: Class of 2026 (859)
Non-profit (277)
Now hiring (7)
Obesity (95)
Opinion (41)
Ovarian cancer (68)
Pain (43)
Pancreatic cancer (74)
Parkinson's disease (104)
Partnered (6)
Patents (133)
Patient recruitment (154)
Peanut (17)
People (17128)
Pharmaceutical (8)
Phase 1 (6087)
Phase 2 (7372)
Phase 3 (3786)
Pipeline (1447)
Policy (33)
Postmarket research (209)
Preclinical (2630)
Press Release (51)
Prostate cancer (48)
Psychedelics (5)
Radiopharmaceuticals (51)
Rare diseases (168)
Real estate (1461)
Recruiting (10)
Regulatory (3429)
Reports (15)
Research institute (311)
Resumes & cover letters (20)
Rett syndrome (9)
RNA editing (4)
RSV (13)
Schizophrenia (17)
Series A (91)
Series B (73)
Service/supplier (2)
Sickle cell disease (24)
Special edition (3)
Spinal muscular atrophy (40)
Sponsored (5)
Startups (991)
State (1)
Stomach cancer (2)
Supply chain (22)
Tariffs (9)
The Weekly (4)
Vaccines (122)
Venture capital (19)
Weight loss (41)
Women's health (8)
Worklife (2)
Date
Last 7 days (151)
Last 30 days (568)
Last 365 days (8457)
2026 (785)
2025 (8540)
2024 (9141)
2023 (9881)
2022 (11995)
2021 (12643)
2020 (9850)
2019 (6672)
2018 (5275)
2017 (6073)
2016 (5592)
2015 (6439)
2014 (4922)
2013 (4061)
2012 (4400)
2011 (4870)
2010 (4514)
Location
Africa (144)
Alabama (52)
Alaska (1)
Arizona (35)
Arkansas (2)
Asia (8937)
Australia (2079)
California (3622)
Canada (902)
China (274)
Colorado (72)
Connecticut (127)
Delaware (56)
Europe (19486)
Florida (375)
Georgia (54)
Hawaii (2)
Idaho (11)
Illinois (180)
India (17)
Indiana (194)
Iowa (3)
Japan (105)
Kansas (14)
Kentucky (3)
Louisiana (3)
Maine (2)
Maryland (374)
Massachusetts (2726)
Michigan (97)
Minnesota (157)
Mississippi (1)
Missouri (11)
Montana (10)
Nebraska (2)
Nevada (23)
New Hampshire (7)
New Jersey (679)
New Mexico (6)
New York (799)
North Carolina (440)
North Dakota (5)
Northern California (1775)
Ohio (66)
Oklahoma (7)
Oregon (7)
Pennsylvania (629)
Puerto Rico (8)
Rhode Island (5)
South America (202)
South Carolina (4)
Southern California (1432)
Tennessee (23)
Texas (469)
United States (11400)
Utah (35)
Virginia (27)
Washington D.C. (9)
Washington State (507)
West Virginia (1)
Wisconsin (21)
136,392 Results for "imstem biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
December 23, 2025
·
3 min read
Biotech Bay
AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001
AgeX Therapeutics, Inc. announced today that ImStem Biotechnology, Inc. (“ImStem”), a biopharmaceutical company developing human embryonic stem cell (ESC)-derived mesenchymal stem cells, has dosed the first U.S. multiple sclerosis (MS) patient with ImStem’s lead investigational drug candidate IMS001 at the Shepherd Center in Atlanta, GA.
November 30, 2021
·
6 min read
Press Releases
Abivax to be Added to Nasdaq Biotechnology Index
December 19, 2025
·
1 min read
Press Releases
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - January 27, 2026
January 28, 2026
·
1 min read
Press Releases
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
February 6, 2026
·
15 min read
Press Releases
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)
December 24, 2025
·
4 min read
Press Releases
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
January 20, 2026
·
2 min read
Press Releases
Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)
December 17, 2025
·
1 min read
Press Releases
Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)
December 22, 2025
·
1 min read
Press Releases
Myllia Biotechnology Launches Global Virtual Cell Challenge “Echoes of Silenced Genes”
January 22, 2026
·
1 min read
1 of 13,640
Next
